Live Breaking News & Updates on Cell Therapeutics Trading Down
Stay updated with breaking news from Cell therapeutics trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report sent to investors on Friday. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Down 7.0 % Shares of NASDAQ BCLI opened at $0.54 on Friday. The firm has a 50 day […] ....
BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Wasatch Advisors LP reduced its position in shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) by 0.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 612,088 shares of the company’s stock after selling 3,990 shares during the period. Wasatch Advisors […] ....
Long Focus Capital Management LLC decreased its holdings in shares of Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) by 18.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 175,000 shares of the company’s stock after selling 40,000 shares during […] ....
Cantor Fitzgerald reiterated their overweight rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $6.00 price target on the stock. Separately, HC Wainwright restated a buy rating and issued a $7.00 price objective on shares of Lineage Cell […] ....